News
Updates about Leica Biosystems.
VISTA, California, September 30, 2025 – Leica Biosystems is proud to announce the launch of CytoVision DX, a next-generation image capture, analysis, and case management system purpose-built for clinical cytogenetics laboratories. Now CE-IVDR cleared and Windows 11 compatible, CytoVision DX sets a…
First large-scale program in the state lays foundation for AI applications and aims to enhance speed, precision and access in pathology services. TAMPA, Fla. and VISTA, Calif. (Sept. 25, 2025) — Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Moffitt Cancer Center…
SEPTEMBER 2025 – Leica Biosystems (LBS), a global leader in cancer diagnostics, is proud to announce a new Strategic Distribution Agreement with Scientific Laboratory Supplies (SLS). Through this partnership, SLS will now offer LBS’s comprehensive Life Science portfolio to customers across the UK…
Multiple NHS trusts within South West London Pathology chose HALO AP® and Leica Biosystems Aperio GT 450 DX for their digital pathology solutions. With 45 pathologists and over half a million whole slide images (WSIs) produced annually, this network of London trusts deploys Aperio GT 450 DX…
Coventry, UK and Vista, CA– 6 Sep 2025 – Histofy, a leading innovator in AI-powered pathology, today announced a customer-centric collaboration with Leica Biosystems, a global leader in anatomic and digital pathology solutions. Under this agreement, Leica Biosystems will act as a reseller and…
VISTA, California, September 5, 2025 — In a major leap forward to enable digital transformation of clinical diagnostics, Leica Biosystems proudly showcases its latest, trailblazing additions to the Aperio Digital Pathology portfolio at booth #121 during the 37th European Congress of Pathology. The…
VISTA, California, June 25, 2025 – In a significant stride toward transforming the future of cancer diagnostics and research, Leica Biosystems proudly showcases its latest digital pathology portfolio solutions at booth #50 during the European Congress on Digital Pathology. Designed to meet the…
Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for rapid diagnostics research, development and commercialization Danaher, through its Centers for Enabling…